245 related articles for article (PubMed ID: 2358779)
21. Interleukin-1 augments the interleukin-2-dependent generation of natural killer cells from bone marrow precursors.
Migliorati G; Cannarile L; D'Adamio L; Herberman RB; Riccardi C
Nat Immun Cell Growth Regul; 1987; 6(6):306-15. PubMed ID: 3502358
[TBL] [Abstract][Full Text] [Related]
22. Suppression of natural killer cell differentiation by activated T lymphocytes in long-term cultures of mouse bone marrow.
Delfino DV; Lepri E; Ayroldi E; Migliorati G; Boggs SS; Riccardi C
Exp Hematol; 1998 Jan; 26(1):2-9. PubMed ID: 9430508
[TBL] [Abstract][Full Text] [Related]
23. Precursor phenotype of lymphokine-activated killer cells in the mouse.
Salup RR; Mathieson BJ; Wiltrout RH
J Immunol; 1987 Jun; 138(11):3635-9. PubMed ID: 3108370
[TBL] [Abstract][Full Text] [Related]
24. Differentiation in vitro of T3+ large granular lymphocytes with characteristic cytotoxic activity from an isolated hematopoietic progenitor colony.
Minato N; Hattori M; Sudo T; Kano S; Miura Y; Suda J; Suda T
J Exp Med; 1988 Mar; 167(3):762-76. PubMed ID: 3258352
[TBL] [Abstract][Full Text] [Related]
25. Stromal cells derived from spleen or bone marrow support the proliferation of rat natural killer cells in long-term culture.
Tjota A; Rossi TM; Naughton BA
Proc Soc Exp Biol Med; 1992 Jul; 200(3):431-41. PubMed ID: 1615018
[TBL] [Abstract][Full Text] [Related]
26. Generation of natural killer cells from bone marrow precursors in vitro.
Kalland T
Immunology; 1986 Apr; 57(4):493-8. PubMed ID: 3485566
[TBL] [Abstract][Full Text] [Related]
27. Effect of recombinant murine tumor necrosis factor on the generation of natural killer cells in bone marrow cultures.
Ayroldi E; Sorci G; Cannarile L; Riccardi C
Nat Immun; 1992; 11(2):92-104. PubMed ID: 1498522
[TBL] [Abstract][Full Text] [Related]
28. Hypothalamic control of the generation of mature natural killer lymphocytes in bone marrow and spleen of the mouse.
Belluardo N; Mudó G; Cardile V; Migliorati G; Riccardi C; Cella S; Bindoni M
Nat Immun Cell Growth Regul; 1990; 9(1):26-35. PubMed ID: 2184351
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 3 is a major negative regulator of the generation of natural killer cells from bone marrow precursors.
Kalland T
J Immunol; 1986 Oct; 137(7):2268-71. PubMed ID: 2876040
[TBL] [Abstract][Full Text] [Related]
30. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
Klingemann HG; Deal H; Reid D; Eaves CJ
Exp Hematol; 1993 Aug; 21(9):1263-70. PubMed ID: 8330650
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
32. Population dynamics of natural killer cells in the spleen and bone marrow of normal and leukemic mice during in vivo exposure to interleukin-2.
Christopher FL; Dussault I; Miller SC
Immunobiology; 1991 Dec; 184(1):37-52. PubMed ID: 1800310
[TBL] [Abstract][Full Text] [Related]
33. Generation of natural killer cell lines from murine long-term bone marrow cultures.
Yung YP; Okumura K; Moore MA
J Immunol; 1985 Mar; 134(3):1462-8. PubMed ID: 3968424
[TBL] [Abstract][Full Text] [Related]
34. Lymphokine-activated killer cells derived from murine bone marrow: age-associated difference in precursor cell populations demonstrated by response to interferon.
Kawakami K; Bloom ET
Cell Immunol; 1988 Oct; 116(1):163-71. PubMed ID: 3139303
[TBL] [Abstract][Full Text] [Related]
35. Generation and characterization of purified adherent lymphokine-activated killer cells in mice.
Gunji Y; Vujanovic NL; Hiserodt JC; Herberman RB; Gorelik E
J Immunol; 1989 Mar; 142(5):1748-54. PubMed ID: 2783950
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the stage in natural killer cell development in 14.5-day mouse fetal liver using adult bone marrow stroma.
Lu J; Patrene KD; Appasamy PM; Herberman RB; Boggs SS
Exp Hematol; 1999 Jun; 27(6):1046-56. PubMed ID: 10378894
[TBL] [Abstract][Full Text] [Related]
37. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
[TBL] [Abstract][Full Text] [Related]
38. Characterization of natural killer cells and their precursors in the murine bone marrow.
Silvennoinen O; Renkonen R; Hurme M
Cell Immunol; 1986 Aug; 101(1):1-7. PubMed ID: 3527445
[TBL] [Abstract][Full Text] [Related]
39. Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro.
Verfaillie CM; Catanzarro PM; Li WN
J Exp Med; 1994 Feb; 179(2):643-9. PubMed ID: 8294873
[TBL] [Abstract][Full Text] [Related]
40. Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.
Lotzová E; Savary CA
Nat Immun; 1993; 12(4-5):209-17. PubMed ID: 8257827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
